Assessment of the Health-Related Quality of Life Impact of EUFLEXXA (1% Sodium Hyaluronate) Using Short Form 36 (SF-36) Data Collected in aRandomized Clinical Trial Evaluating Treatment of Osteoarthritis Knee Pain

Hatoum HT^1*, Rosen JE², Fierlinger AL³, Swu-Jane Lin⁴ and Altman RD⁵

¹Center for Pharmacoeconomic Research, University of Illinois at Chicago, Chicago, IL 60612, USA

²Division of Orthopaedics and Rehabilitation, The Bone and Joint Hospital of Queens, New York Hospital Queens, Flushing, NY 11355, USA

³Ferring Pharmaceuticals Inc., Parsippany, NJ 07054, USA

⁴College of Pharmacy, University of Illinois at Chicago, Chicago, IL 60612, USA

⁵Division of Rheumatology and Immunology, Department of Medicine, University of California, Los Angeles, Los Angeles, CA 91390, USA

^*Corresponding Author: